Intravenous glial growth factor 2 (GGF2) isoform of neuregulin-1β improves left ventricular function, gene and protein expression in rats after myocardial infarction.
Recombinant Neuregulin (NRG)-1β has multiple beneficial effects on cardiac myocytes in culture, and has potential as a clinical therapy for heart failure (HF). A number of factors may influence the effect of NRG-1β on cardiac function via ErbB receptor coupling and expression. We examined the effect...
Main Authors: | Michael F Hill, Amish V Patel, Abigail Murphy, Holly M Smith, Cristi L Galindo, Laura Pentassuglia, Xuyang Peng, Carrie G Lenneman, Oghenerukevwe Odiete, David B Friedman, Marvin W Kronenberg, Siyuen Zheng, Zhongming Zhao, Yanna Song, Frank E Harrell, Maya Srinivas, Anindita Ganguly, Jennifer Iaci, Tom J Parry, Anthony O Caggiano, Douglas B Sawyer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3578842?pdf=render |
Similar Items
-
Guidelines for IP version independence in GGF specifications
by: Chown, Tim, et al.
Published: (2005) -
Neuregulin-1: a novel regulator of glial response in spinal cord injury
by: Hardeep Kataria, et al.
Published: (2017-01-01) -
Characterization of Glial Cell Models and In Vitro Manipulation of the Neuregulin1/ErbB System
by: Davide Pascal, et al.
Published: (2014-01-01) -
Populations of radial glial cells respond differently to reelin and neuregulin1 in a ferret model of cortical dysplasia.
by: Sylvie Poluch, et al.
Published: (2010-10-01) -
Alteration of serum neuregulin 4 and neuregulin 1 in gestational diabetes mellitus
by: Lei Zhang, et al.
Published: (2021-10-01)